Operator
Good day, everyone, and welcome to Myovant Sciences first-quarter of fiscal year 2021 earnings conference call. Today s call is being recorded. At this time, I would like to turn the call over to Ryan Crowe, vice president of investor relations at Myovant. Please go ahead.
Ryan Crowe
Vice President of Investor Relations
Thank you, operator. Good morning and thanks for joining us today to review the financial results of Myovant s first quarter of fiscal year 2021 and to discuss other corporate and business updates. Joining me for today s call are Dave Marek, Myovant s chief executive officer; Frank Karbe, president and chief financial officer; Lauren Merendino, chief commercial officer; and Dr. Juan Camilo Arjona, chief medical officer.